Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutationCLINICAL MICROBIOLOGY AND INFECTIONIF8.52022-12-0112OA
Genomic evolution towards azole resistance in Candida glabrata clinical isolates unveils the importance of CgHxt4/6/7 in azole accumulationCOMMUNICATIONS BIOLOGYIF5.12022-10-212OAAI
The transcription factor Ndt80 is a repressor of Candida parapsilosis virulence attributes转录因子Ndt80是一种抑制副念珠菌毒力属性VIRULENCEIF5.42021-02-048OAAI
FKS1 mutation associated with decreased echinocandin susceptibility of Aspergillus fumigatus following anidulafungin exposureSCIENTIFIC REPORTSIF3.92020-07-2013OAAI
Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistanceCLINICAL MICROBIOLOGY AND INFECTIONIF8.52017-08-0151OAAI
Fluconazole and Voriconazole Resistance in Candida parapsilosis Is Conferred by Gain-of-Function Mutations in MRR1 Transcription Factor GeneANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52015-10-0146OAAI
Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp.FRONTIERS IN MICROBIOLOGYIF4.52015-03-12175OAAI
In vitro antifungal activity and in vivo antibiofilm activity of cerium nitrate against Candida speciesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62015-01-0324OAAI
Anti-biofilm activity of low-molecular weight chitosan hydrogel against Candida speciesMEDICAL MICROBIOLOGY AND IMMUNOLOGYIF32013-09-0861PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向